Jefferies Financial Group started coverage on shares of Tyra Biosciences (NASDAQ:TYRA) in a research note released on Monday morning, Price Targets.com reports. The firm issued a buy rating and a $19.00 target price on the stock.
Separately, Cowen began coverage on shares of Tyra Biosciences in a research report on Monday. They set an outperform rating for the company.
Shares of NASDAQ TYRA opened at $16.38 on Monday. Tyra Biosciences has a 12-month low of $12.70 and a 12-month high of $29.90.
Read More: Commodities
Receive News & Ratings for Tyra Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyra Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.